There have been 50 recent insider transactions recorded for Biomea Fusion, Inc. (BMEA), including 37 buys and 6 sells. Total insider buying was valued at $33.01M and total insider selling at $19.51M.
Notable insiders with recent activity include Erdtmann Rainer M, Hitchcock Michael J.m., Chen Bihua. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — BMEA
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Erdtmann Rainer M |
See Remarks |
RSU Award |
452,512 |
$1.49 |
$674.24K |
452,512 |
| 2026-04-01 |
Hitchcock Michael J.m. |
Interim CEO |
RSU Award |
667,477 |
$1.49 |
$994.54K |
667,477 |
| 2025-12-31 |
Erdtmann Rainer M |
See Remarks |
Unknown |
- |
- |
- |
174,614 |
| 2025-12-11 |
Erdtmann Rainer M |
See Remarks |
Informative Buy |
30,000 |
$1.43 |
$43K |
723,027 |
| 2025-12-02 |
Hitchcock Michael J.m. |
Interim CEO |
Informative Buy |
100,000 |
$0.99 |
$99.18K |
115,000 |
| 2025-12-01 |
Erdtmann Rainer M |
See Remarks |
Informative Buy |
10,000 |
$1.05 |
$10.5K |
693,027 |
| 2025-11-28 |
Erdtmann Rainer M |
See Remarks |
Informative Buy |
40,000 |
$1.10 |
$44.05K |
683,027 |
| 2025-08-11 |
Erdtmann Rainer M |
See Remarks |
RSU Award |
1,246,989 |
$1.53 |
$1.91M |
1,246,989 |
| 2025-08-11 |
Hitchcock Michael J.m. |
Interim CEO |
RSU Award |
916,434 |
$1.53 |
$1.4M |
916,434 |
| 2025-08-01 |
Chen Bihua |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-07-22 |
Averill Julianne |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-07-22 |
Averill Julianne |
Director |
RSU Award |
241,177 |
$1.82 |
$438.94K |
241,177 |
| 2025-06-11 |
Aguiar Eric |
Director |
RSU Award |
91,970 |
$2.50 |
$229.93K |
91,970 |
| 2025-06-11 |
Faust Elizabeth |
Director |
RSU Award |
91,970 |
$2.50 |
$229.93K |
91,970 |
| 2025-06-11 |
Ray Sumita |
Director |
RSU Award |
91,970 |
$2.50 |
$229.93K |
91,970 |
| 2025-06-11 |
Chen Bihua |
10 Percent Owner |
RSU Award |
91,970 |
$2.50 |
$229.93K |
91,970 |
| 2025-03-26 |
Hitchcock Michael J.m. |
Interim CEO |
RSU Award |
350,000 |
$2.52 |
$882K |
350,000 |
| 2025-01-31 |
Erdtmann Rainer M |
See Remarks |
Gift (Received) |
10,000 |
- |
- |
19,400 |
| 2025-01-28 |
Erdtmann Rainer M |
See Remarks |
Gift (Given) |
40,000 |
- |
- |
673,027 |
| 2024-11-30 |
Valle Franco |
Chief Financial Officer |
RSU Award |
495 |
$6.15 |
$3.05K |
42,995 |
| 2024-09-30 |
Hitchcock Michael J.m. |
Director |
Informative Buy |
10,000 |
$10.06 |
$100.6K |
15,000 |
| 2024-06-12 |
Aguiar Eric |
Director |
RSU Award |
51,025 |
$4.63 |
$236.25K |
51,025 |
| 2024-06-12 |
Faust Elizabeth |
Director |
RSU Award |
51,025 |
$4.63 |
$236.25K |
51,025 |
| 2024-06-12 |
Ray Sumita |
Director |
RSU Award |
51,025 |
$4.63 |
$236.25K |
51,025 |
| 2024-06-12 |
Chen Bihua |
10 Percent Owner |
RSU Award |
51,025 |
$4.63 |
$236.25K |
51 |
| 2024-06-12 |
Hitchcock Michael J.m. |
Director |
RSU Award |
51,025 |
$4.63 |
$236.25K |
51,025 |
| 2024-06-11 |
Valle Franco |
Chief Financial Officer |
Informative Buy |
12,509 |
$4.43 |
$55.36K |
42,500 |
| 2024-05-31 |
Valle Franco |
Chief Financial Officer |
RSU Award |
4,448 |
$3.78 |
$16.82K |
29,991 |
| 2024-05-31 |
Frias Juan Pablo |
Chief Medical Officer |
RSU Award |
349 |
$8.94 |
$3.12K |
349 |
| 2024-01-17 |
Erdtmann Rainer M |
President and COO |
RSU Award |
135,700 |
$14.44 |
$1.96M |
135,700 |
| 2024-01-17 |
Valle Franco |
Chief Financial Officer |
RSU Award |
145,245 |
$14.44 |
$2.1M |
145,245 |
| 2024-01-17 |
Butler Thomas Andrew |
10 Percent Owner, Officer: Chief Executive Officer |
RSU Award |
407,502 |
$14.44 |
$5.88M |
407,502 |
| 2024-01-17 |
Frias Juan Pablo |
Chief Medical Officer |
RSU Award |
111,090 |
$14.44 |
$1.6M |
111,090 |
| 2023-12-29 |
Erdtmann Rainer M |
President and COO |
Gift (Received) |
3,000 |
- |
- |
9,400 |
| 2023-11-30 |
Valle Franco |
Chief Financial Officer |
RSU Award |
1,345 |
$3.78 |
$5.09K |
25,543 |
| 2023-08-31 |
Frias Juan Pablo |
Officer |
Unknown |
- |
- |
- |
- |
| 2023-08-31 |
Frias Juan Pablo |
Chief Medical Officer |
RSU Award |
300,000 |
$16.87 |
$5.06M |
300,000 |
| 2023-06-14 |
Aguiar Eric |
Director |
RSU Award |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-14 |
Faust Elizabeth |
Director |
RSU Award |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-14 |
Ray Sumita |
Director |
RSU Award |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-14 |
Chen Bihua |
10 Percent Owner |
RSU Award |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-14 |
Hitchcock Michael J.m. |
Director |
RSU Award |
6,989 |
$38.90 |
$271.87K |
6,989 |
| 2023-06-01 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informative Sell |
50,000 |
$34.56 |
$1.73M |
3,500,000 |
| 2023-05-31 |
Valle Franco |
Chief Financial Officer |
RSU Award |
4,273 |
$3.78 |
$16.16K |
24,198 |
| 2023-05-31 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informative Sell |
75,000 |
$33.81 |
$2.54M |
3,550,000 |
| 2023-05-12 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informative Sell |
25,000 |
$33.84 |
$846K |
3,625,000 |
| 2023-05-09 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informative Sell |
150,000 |
$34.50 |
$5.18M |
3,650,000 |
| 2023-05-08 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informative Sell |
100,000 |
$33.99 |
$3.4M |
3,800,000 |
| 2023-04-20 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informative Sell |
200,000 |
$29.12 |
$5.82M |
3,900,000 |
| 2023-03-31 |
A2a Pharmaceuticals, Inc. |
10 Percent Owner |
Informative Buy |
200,000 |
$31.25 |
$6.25M |
4,100,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
